A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients

BACKGROUND: Glioblastoma (GBM) remains the most biologically aggressive subtype of gliomas with an average survival of 10 to 12 months. Considering that the overall survival (OS) of each GBM patient is a key factor in the treatment of individuals, it is meaningful to predict the survival probability...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingchen, Yan, Zhengwei, He, Xiaona, Zhang, Cheng, Yu, Huiqiang, Lu, Quqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456771/
https://www.ncbi.nlm.nih.gov/pubmed/30859746
http://dx.doi.org/10.1002/brb3.1258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456771/
https://www.ncbi.nlm.nih.gov/pubmed/30859746
http://dx.doi.org/10.1002/brb3.1258

Ejemplares similares